BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26365503)

  • 1. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients.
    Hocquelet A; Balageas P; Laurent C; Blanc JF; Frulio N; Salut C; Cassinotto C; Saric J; Possenti L; Bernard PH; Montaudon M; Trillaud H
    Int J Hyperthermia; 2015; 31(7):749-57. PubMed ID: 26365503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
    Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
    J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
    Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
    Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
    Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
    Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria.
    Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee FY; Huo TI
    Ann Surg Oncol; 2013 Jun; 20(6):2035-42. PubMed ID: 23306955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes.
    Min JH; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Sinn DH; Kim JM; Sohn I
    Clin Radiol; 2018 Jul; 73(7):676.e15-676.e24. PubMed ID: 29709236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis.
    Wang WD; Zhang LH; Ni JY; Jiang XY; Chen D; Chen YT; Sun HL; Luo JH; Xu LF
    Korean J Radiol; 2018; 19(4):613-622. PubMed ID: 29962868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials.
    Jia Z; Zhang H; Li N
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1769-1777. PubMed ID: 33569810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
    Wong KM; Yeh ML; Chuang SC; Wang LY; Lin ZY; Chen SC; Tsai JF; Wang SN; Kuo KK; Dai CY; Yu ML; Lee KT; Chuang WL
    Indian J Gastroenterol; 2013 Jul; 32(4):253-7. PubMed ID: 22932964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.
    Lai EC; Tang CN
    Int J Surg; 2013; 11(1):77-80. PubMed ID: 23220487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
    Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.